Study of Orforglipron in Participants With Peripheral Artery Disease
About this study
Are you Struggling With Peripheral Artery Disease?
The purpose of this study is to evaluate the effect and safety of orforglipron once daily in participants with Fontaine II peripheral arterial disease (PAD). Participation in the study will last about 58 weeks.
Would you like to take part?
As a volunteer in a research study, you’ll receive study-related medical care from the study doctor and regular follow-up of your health to monitor the effectiveness of the care you’ll receive. The results of this research will be used to find out if the investigational medication being studied will be of benefit to others struggling with PAD, and whether it will be made widely available to all Canadians trying to manage PAD. Study volunteers are an important part of moving medical care forward.
Who may qualify
- Have symptomatic PAD with intermittent claudication of Fontaine Stage II
- Have an Ankle Brachial Index (ABI) of 0.9 or less
- Have a body mass index (BMI) less than 23 kilogram per square meter (kg/m2)
- Have Hemoglobin A1c (HbA1c) greater than 10%
- Have walking ability limited by conditions other than PAD
- Have a planned lower limb surgery or any other surgery affecting walking ability
- Had a peripheral revascularization procedure within 90 days prior to the day of screening or planning to undergo peripheral revascularization during the clinical trial
- Had a stroke, transient ischemic attack, myocardial infarction, coronary or carotid revascularization, or hospitalization for unstable angina pectoris within 60 days prior to screening
- Have heart failure presently classified as being in New York Heart Association class III – IV
What participation may involve
- Regular visits with the study team at no cost
- Study assessments and health monitoring throughout
- Check-ins between visits
- Informed consent before anything begins — questions welcome
What participants may receive
- Study-related care from a physician-led team
- Study assessments at no cost
- Reimbursement for reasonable travel, where applicable
Where this study is enrolling
Learn more
Cardiovascular disease
Cardiovascular disease is a group of conditions affecting the heart and the blood vessels that carry blood around your body. The most common form in Canada is ischemic…
Read about this condition →Other studies you can explore
All current studies →
RecruitingA Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight Without Type 2 DiabetesSarniaCheck availability →
RecruitingA Study for Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney DiseaseSarnia · MontrealCheck availability →
RecruitingHypertension Study for Subjects With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseSarnia · MontrealCheck availability →


